• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing

Centene Has Made a Top So Become a Seller

Here's what trades should do.
By BRUCE KAMICH
Feb 10, 2022 | 01:34 PM EST

Back on October 27 we reviewed the charts of Centene and wrote that "I am in no rush to go long CNC and I do not want to anticipate its next move. However, I will recommend a purchase on a breakout over $76."
 
On Tuesday the company reported an earnings beat but its market reaction has been underwhelming. Let's dig into the charts and indicators.  
 
In this daily bar chart of CNC, below, we can see that prices pierced the $76 level in November and have climbed higher since. Prices are above the rising 50-day moving average line and the rising 200-day line. Trading volume has weakened since the middle of December but the On-Balance-Volume (OBV) line has risen to a slight new high.
 
The 12-day price momentum study is making a lower high from December to February even though prices made a new high. This is a bearish divergence. 
 
 
 
In this weekly Japanese candlestick chart of CNC, below, we can see that prices broke out over $75 and rallied to the $85 area but then retested the breakout at $75. A new rally is two weeks old but trading volume is not expanding.
 
Like the daily OBV line the weekly OBV line is going up.
 
The 12-week price momentum study is showing that the current rally is weaker than the December advance.
 
 
 
In this daily Point and Figure chart of CNC, below, we can see a price target of $108. I am not sure what price will turn this chart bearish. 
 
Bottom line strategy: It looks like CNC has made a short-term top reversal with an earnings beat. When prices decline on good news it is a sign to sell. Traders who are long CNC should sell and take their profits. 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are prohibited from trading individual securities.

TAGS: Investing | Stocks | Technical Analysis | Trading | Healthcare

More from Investing

Buying Momentum SNAPs Under Weight of Recession Worries

James "Rev Shark" DePorre
May 24, 2022 4:26 PM EDT

The Dow held its own, but under the surface it wasn't so pretty as the correction churns on.

Meta Platforms: I'm Looking at the Charts, Not the Headlines

Bruce Kamich
May 24, 2022 2:30 PM EDT

Buyers have been attracted in the $180 area in March, April and now.

Boston Scientific Could Be Wicked Good in This Kind of Market

Brad Ginesin
May 24, 2022 2:13 PM EDT

Here's why this healthcare stock is a potential port in the storm for investors.

Bettin' a Buck on Devon

Mark Sebastian
May 24, 2022 1:39 PM EDT

Here's where I see Devon Energy going and how to play it.

Can This China Tech ETF Surprise on the Upside?

Bruce Kamich
May 24, 2022 1:18 PM EDT

Sometimes the most uncomfortable trade can be the best trade.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 02:24 PM EDT PAUL PRICE

    An Interesting Chart

    I'm betting heavily that stocks will be way up aga...
  • 10:10 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    "Market Timing for Dummies"
  • 01:44 PM EDT STEPHEN GUILFOYLE

    Stocks Under $10 Portfolio

    We're making a series of trades here.
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login